Can Eye Scans Forecast Parkinson's Disease?
How do eye scans detect signs of Parkinson's disease?
Eye scans for detecting signs of Parkinson's disease involve analysing various aspects of eye movement and structure. This non-invasive approach has shown potential for identifying early signs of the disease. Researchers have found specific changes in eye movement patterns and linked them with structural characteristics of Parkinson's disease.
 |
| Eye Scans and the Possibility of Parkinson's Prediction |
How the process generally works:
- Eye Movement Analysis: Parkinson's disease can affect the control of eye movements due to its impact on motor functions. Eye movement abnormalities, such as saccadic impairments (uncontrolled rapid eye movements), reduced blink rates, and alterations in smooth pursuit movements, have been observed in individuals with Parkinson's disease. Experts can detect these abnormalities through eye-tracking technology.
- Pupil Abnormalities: People with Parkinson's often exhibit changes in pupil size and responsiveness to light. Pupillary abnormalities, such as reduced pupillary light reflexes, can indicate the disease. The dysfunction of the autonomic nervous system, which controls involuntary bodily functions, is attributed to these changes.
- Retinal Imaging: The retina, located at the back of the eye, can provide valuable information about the health of the nervous system. Studies have shown that changes in the retinal structure and thickness can be associated with Parkinson's disease. Retinal imaging techniques, such as optical coherence tomography (OCT), can capture detailed retinal images and help identify abnormalities.
- Biomarkers: Researchers are exploring the use of specific biomarkers in the eye to indicate Parkinson's disease. Protein aggregates like alpha-synuclein in the brains of individuals with Parkinson's could constitute these biomarkers. Detecting these biomarkers in the eye could potentially offer an early diagnostic tool.
- Machine Learning and AI: Advanced data analysis techniques, such as machine learning and artificial intelligence, can play a crucial role in identifying patterns and anomalies in eye scan data. By training algorithms on large datasets of healthy and Parkinson 's-afflicted individuals, these technologies can learn to understand subtle differences that might not be apparent to the human eye.
Parkinson's disease has the potential to impact the eyes, leading to alterations in vision, dryness of the eyes, and challenges with reading. Researchers at Moorfields Eye Hospital and the UCL Institute of Ophthalmology have identified distinct indicators within the eye that signal Parkinson's disease. According to scientists, these indicators are detectable on average seven years before an individual obtains an official diagnosis.
How do ophthalmologists use OCT scans to spot Parkinson’s signs?
Ophthalmologists employ OCT (optical coherence tomography) scans to identify signs of Parkinson's disease by assessing the structural changes in the retina. This advanced imaging technique uses light waves to create detailed cross-sectional images of the retina, allowing for precise analysis.
How experts use OCT scans for this purpose
- Retinal Thickness Analysis: Parkinson's disease can lead to changes in the thickness of the retinal layers, particularly the ganglion cell layer and the inner plexiform layer. Ophthalmologists use OCT scans to measure these thicknesses and identify deviations from the norm.
- Macular Degeneration: Parkinson's patients may exhibit alterations in the macular region responsible for central vision. OCT scans enable ophthalmologists to detect macular degeneration or irregularities, which can indicate the disease.
- RNFL Thinning: The retinal nerve fibre layer (RNFL) can experience thinning due to neurodegenerative processes like Parkinson's. OCT scans can provide precise measurements of RNFL thickness, and significant thinning could signal potential Parkinson 's-related changes.
- Blood Vessel Changes: OCT angiography is an advanced technique that examines blood vessels within the retina. Changes in blood vessel density or irregular patterns can link to Parkinson's disease.
- Ganglion Cell Analysis: The ganglion cells have a vital role in the retina in transmitting visual information. OCT scans can aid in assessing the health of these cells, as researchers have linked Parkinson's with abnormalities in ganglion cell density.
- Alpha-Synuclein Deposits: Researchers are exploring the possibility of detecting alpha-synuclein protein aggregates in the retina, as these aggregates are a hallmark of Parkinson's disease. Drs use OCT scans to identify these deposits.
- Comparative Analysis: Ophthalmologists often compare the OCT scan results of individuals with suspected Parkinson's to those of healthy individuals. By identifying distinctive differences in retinal structure, they can potentially identify early signs of the disease.
It is important to note that while OCT scans show promise, they are not currently a definitive diagnostic tool for Parkinson's disease. Ongoing research aims to refine the technique and establish its accuracy in detecting Parkinson 's-related changes in the eye.
Do doctors require Parkinson's markers to diagnose the disease?
No, doctors do not necessarily need Parkinson's markers to diagnose the disease. The diagnosis often relies on a combination of clinical symptoms, medical history, physical examination, and sometimes additional tests like imaging studies. While Parkinson's markers can offer valuable insights, experts establish them without them. A team of researchers from UCL and Moorfields Eye Hospital has identified indicators that signify the presence of Parkinson's disease in patients, typically around seven years before clinical symptoms become apparent.
Parkinson's disease is a progressive neurological disorder marked by a decline in dopamine levels. Post-mortem analysis of individuals with Parkinson's disease has revealed variations in the inner nuclear layer (INL). Previous research utilising OCT scans has detected potential morphological irregularities linked to the condition, although there have been discrepancies. The eye works as an easily accessible portal to the brain with the neurotransmitter dopamine.
This study validated earlier findings of a notably thinner ganglion cell-inner plexiform layer (GCIPL) and, for the first time, identified a thinner INL. Additionally, the study established a connection between reduced thickness in these layers and an elevated susceptibility to developing Parkinson's disease. This heightened risk was observed independently of other factors or coexisting medical conditions.
If you have concerns about optic nerve issues and Parkinson's disease, it is advisable to seek a comprehensive evaluation and diagnosis from a medical professional.
Ref:
https://www.parkinsons.org.uk/news/eye-scans-detect-signs-parkinsons-7-years-diagnosis
https://www.standard.co.uk/news/health/eye-scans-detect-signs-of-parkinson-s-disease-up-to-seven-years-before-diagnosis-b1102000.html